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Adenovirus E1A Directly Targets the E2F/DP-1 Complex䌤
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Deregulation of the cell cycle is of paramount importance during adenovirus infection. Adenovirus normally
infects quiescent cells and must initiate the cell cycle in order to propagate itself. The pRb family of proteins
controls entry into the cell cycle by interacting with and repressing transcriptional activation by the E2F
transcription factors. The viral E1A proteins indirectly activate E2F-dependent transcription and cell cycle
entry, in part, by interacting with pRb and family members to free the E2Fs. We report here that an E1A 13S
isoform can unexpectedly activate E2F-responsive gene expression independently of binding to the pRb family
of proteins. We demonstrate that E1A binds to E2F/DP-1 complexes through a direct interaction with DP-1.
E1A appears to utilize this binding to recruit itself to E2F-regulated promoters, and this allows the E1A 13S
protein, but not the E1A 12S protein, to activate transcription independently of interaction with pRb. Importantly, expression of E1A 13S, but not E1A 12S, led to significant enhancement of E2F4 occupancy of E2F sites
of two E2F-regulated promoters. These observations identify a novel mechanism by which adenovirus deregulates the cell cycle and suggest that E1A 13S may selectively activate a subset of E2F-regulated cellular genes
during infection.

simian adenoviruses, and these are referred to as conserved
region 1 (CR1) to CR4 (1, 3).
Immunoprecipitation of E1A-bound proteins with anti-E1A
antibodies detected a variety of coprecipitating cellular polypeptides ranging in size from 30 to 400 kDa (2). The first of
these proteins to be identified was pRb, a key regulator of exit
from the G1 phase of the cell cycle (33). E1A similarly targets
p107 and p130, two other pRb family members (2). Overexpression of pRb induces cells to arrest in G1 (15), and this is
most closely correlated with its ability to repress activation
from E2F-responsive elements (6). E2F is a heterodimeric
transcription factor containing one of six E2Fs and one of
three DP family members (11, 17). Two other members of the
E2F family, E2F7 and E2F8, are somewhat different in that
they do not dimerize with DP proteins (17). Individual E2F
family members may function primarily as activators or repressors of transcription, and they control the expression of genes
required for cell cycle progression (4, 8, 11, 20, 31). The main
regulator of pRb binding to E2F is phosphorylation of pRb
(13). Hyperphosphorylation of pRb inhibits its binding to E2F
and leads to stimulation of cell proliferation. The region of
E1A that is responsible for binding to pRb and inhibiting its
interaction with E2Fs is the CR2 domain, with a portion of the
CR1 domain stabilizing the interaction and displacing E2Fs
(2). E1A 12S overcomes the repression of E2F-regulated genes
to force quiescent cells to enter the cell cycle by eliminating
corepressor complexes consisting of p130-E2F4 and HDAC1/
2-mSin3B from the promoters of E2F-regulated genes (29).
Once these repressive complexes are removed, the promoters
become occupied by activating E2F family members, which
stimulate transcription (29). In summary, E1A interacts with
several pRb family members in order to inhibit their interaction with E2Fs and induce cell cycle entry, as well as to activate

Cells have multiple checkpoints to ensure that aberrant
DNA replication does not occur and to ascertain that the
necessary requirements have been met before entering the cell
cycle. Efficient viral replication within a cell typically requires
that all relevant pathways that could lead to abortive infection
have been closed. Indeed, to ensure a productive replicative
cycle, many viruses encode one or more proteins that target
and block such cellular checkpoints.
Adenovirus normally infects noncycling cells, which are poor
hosts for viral replication. Consequently, these viruses have
evolved proteins that force the host cell into the cell cycle and
induce the expression of the cellular biosynthetic machinery
and substrates that are required for efficient production of viral
progeny. The initiators and the primary executors of cell cycle
modulation in adenovirus-infected cells are the E1A proteins.
These proteins are the first viral gene products expressed during adenovirus infection. Alternative splicing generates five
E1A mRNAs during infection by human adenovirus 5. Two
major products are the 13S and 12S mRNAs, which encode
proteins of 289 and 243 amino acids, respectively (2, 3). There
are four regions within the 13S-encoded E1A protein that are
highly conserved among the different serotypes of human and
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a variety of cellular and viral genes. Interference with pRb
function is only one of several mechanisms by which E1A
activates the cell cycle (2), and it is possible that not all means
by which E1A initiates the cell cycle are known or well understood.
Recently, it was shown that HPV E7 and adenovirus E1A
can interact with E2F6 (21). We were interested in determining whether other classical E2Fs can bind E1A and how this
influences E2F function independently of the interaction of
E1A with pRb. Furthermore, as the influence of E1A on E2F
function has largely been elucidated by using E1A 12S, we
wanted to determine whether there are differences when E1A
13S is present. In the present study, we show that E1A 13S
directly binds to E2F/DP-1 complexes, likely via association
with DP-1. This binding results in activation of E2F-regulated
genes, with E2F4 and E2F5 being activated the most strongly.
Activation is restricted largely to E1A 13S, while E1A 12S has
a minimal effect. We also show that E1A is directly recruited to
E2F-regulated promoters during viral infection and that E1A
13S, but not E1A 12S, can enhance E2F4 promoter occupancy.
These results add to our understanding of how E1A can deregulate the cell cycle and highlight important differences between how E1A 12S and E1A 13S function.
MATERIALS AND METHODS
Cell lines, tissue culture, and viruses. IMR-90, U2OS, and HeLa cells were
grown in Dulbecco’s modified Eagle medium (DMEM; Invitrogen) supplemented with 10% fetal bovine serum (FBS; Invitrogen), streptomycin, and penicillin.
HeLa cells were infected with a multiplicity of infection (MOI) of 10 with the
indicated viruses. dl309 expresses both E1A 13S and 12S, pm975 expresses only
E1A 13S, and dl520 expresses only E1A 12S. Roughly 5 ⫻ 106 cells were infected
with each virus. Infections were carried out for 1 h in serum-free medium, after
which 10 ml of complete medium was added and the cells were incubated for an
additional 16 h. We arrested the growth of IMR-90 cells by allowing them to
become confluent for at least 72 h and serum starving them in 0.2% FBS DMEM.
Stable cell lines with the integrated E2F reporter were made by cotransfection
of U2OS cells with 1 g of pGL-E2F-Luc reporter plasmid and 9 g of a
fragment of the pcDNA3.1-Hygro plasmid encoding the hygromycin resistance
marker. Cells were selected in hygromycin, and a stable pool was used for
subsequent experiments in order to avoid clonal variation.
E1A, E2F, and DP-1 expression vectors and protein purification. E1A12S and
E1A13S cDNAs were cloned into the pcDNA3 mammalian expression vector
(Invitrogen), while the dl1100 series of 13S and 12S E1A deletion mutants were
cloned into pcDNA3.1 (Invitrogen). Enhanced green fluorescent protein
(EGFP) fusions of E1A fragments were generated by cloning the specific fragments into the pEGFP-C1 expression vector (Clontech) in frame with the N-terminal EGFP. Hemagglutinin (HA)-tagged DP-1 expression vectors were described previously (34). Fusion of DP-1 with glutathione S-transferase (GST) was
done by subcloning the cDNA into pGEX-4T1 (GE Healthcare Life Sciences) in
frame with the N-terminal GST tag. His-tagged E1A 13S and E2F1 were made
by subcloning the entire E1A 13S cDNA or E2F1 cDNA into the pET42 vector
(Novagen) in frame with a C-terminal 6⫻His tag. Proteins were expressed in
Escherichia coli strain BL21 and purified on their respective resins according to
the manufacturer’s specifications. GST pulldown assays were carried out as
previously described (25).
Transfection and reporter assay. Twenty-four hours prior to transfection,
U2OS cells were seeded into six-well dishes (Sarstedt) at a density of 100,000 per
well in DMEM. U2OS cells were transfected with 1 g of the reporter plasmid
(pGal6-Luc) and 0.5 g of the transactivator pCMV-E2F and pCMV-DP-1.
Transfections were carried out using the Superfect reagent (Qiagen) according to the manufacturer’s instructions. Luciferase activity was assayed 24 h
after transfection in U2OS cells using the Promega Luciferase Reporter kit
according to the manufacturer’s instructions. Luciferase activity was normalized
to both transfection efficiency using beta-galactosidase activity and protein levels.
Immunoprecipitations. For immunoprecipitation, transfected HeLa cells were
lysed in NP-40 lysis buffer (0.5% NP-40, 50 mM Tris [pH 7.8], 150 mM NaCl)
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supplemented with protease inhibitor cocktail. One milligram of the cell lysate
was used for immunoprecipitation with anti-E1A monoclonal antibody M73 (33).
E1A was detected using the M73 monoclonal antibody, while E2F and DP-1
were detected using anti-HA rat monoclonal antibody (clone 3F10; Roche).
Endogenous DP-1 was detected using WTH24 mouse hybridoma supernatant.
Endogenous E2F4 was detected using a custom rabbit antibody.
ChIP and reprecipitation. Chromatin immunoprecipitation (ChIP) was carried out as previously described (25). Briefly, contact-inhibited, arrested IMR-90
cells were infected with the indicated adenoviruses and harvested 24 h after
infection for ChIP analysis. For immunoprecipitation of E1A, the M73 and M58
monoclonal antibody cocktail was used. For E2F4 ChIPs, a custom polyclonal
rabbit anti-E2F4 antibody was utilized. Mouse anti-rabbit antibody was used as
a negative IgG control (Sigma). Re-ChIPs were carried out by eluting the primary ChIP product with 10 mM dithiothreitol for 15 min three times, pooling the
eluates, and diluting them 10-fold in the original dilution buffer.
PCRs were carried out using 1⫻ iQ-SYBR green SuperMix (Bio-Rad) according to the manufacturer’s directions using 2% of the total ChIP DNA as the
template according to the manufacturer’s instructions and a MyiQ real-time
PCR instrument (Bio-Rad) or a Life Technologies ABI 7900HT sequence detector. The annealing temperature used was 60°C, and 40 cycles were run.
Real-time expression analysis. Contact-inhibited and arrested IMR-90 cells
were infected with dl309, dl520, pm975, E1A 13S ⌬2-11, or the virus with E1
deleted, and 36 h after infection, total cellular RNA was extracted using the
TRIzol reagent (Invitrogen) according to the manufacturer’s instructions. Five
micrograms of total RNA was used in a reverse transcriptase reaction with
SuperScript II reverse transcriptase (Invitrogen) according to the manufacturer’s
guidelines, using random hexanucleotides for priming. The cDNA was subsequently used for real-time expression analysis using an Applied Biosystems ABI
7900HT sequence detector. Fold changes in expression were determined by
comparing expression levels with those obtained in infections with the virus with
E1 deleted and analyzing the expression data using Data Assist software (Life
Technologies).
BrdU incorporation assay. Arrested IMR-90 human primary fibroblasts were
pulsed with 30 M bromodeoxyuridine (BrdU; Sigma) for 1 h at 16 or 24 h after
virus infection. Cells were fixed in 4% paraformaldehyde for 10 min at room
temperature. Cells were permeabilized with 0.2% Triton X-100 in phosphatebuffered saline (PBS), washed three times in PBS-Tween, and blocked for 1 h in
blocking buffer (1% normal goat serum, 1% bovine serum albumin, and 0.2%
Tween 20 in PBS). Primary anti-BrdU mouse monoclonal antibody (Sigma) was
diluted in blocking buffer containing 5 mM MgCl2 and 50 U/ml DNase I and
incubated on cells at 37°C for 80 min. The cells were then washed three times in
PBS-Tween and incubated in an anti-mouse–Alexa Fluor 488 secondary antibody
(Invitrogen) for 30 min at 37°C. Cells were washed three times in PBS-Tween
and mounted using ProLong Gold mounting medium with 4⬘,6-diamidino-2phenylindole (DAPI; Invitrogen). Images were acquired on a Zeiss LSM510
laser scanning confocal microscope. Three random low-power fields of view were
obtained (20⫻ objective lens), and total nuclei were determined using DAPI
staining.
Virus generation. Mutant viruses encoding E1A 13S ⌬2-11 or E1A 12S ⌬2-11
Y47H/C124G were generated by subcloning a fragment of E1A from the ATG
codon to the XbaI site in exon 2 into pXC1-⌬E1A at the EcoRI/XbaI sites.
Either plasmid was then cotransfected with pJM17 into low-passage 293 cells.
After a complete cytopathic effect was observed on the plate, virus was harvested
by freeze-thawing and plaque purified to obtain pure mutant virus, which was
subsequently used in infection experiments.
Virus growth assay. IMR-90 fibroblasts were growth arrested by contact inhibition and infected with pm975 or dl520 at an MOI of 5. Virus was adsorbed for
1 h at 37°C in 5% CO2, after which the medium was removed and cells were
washed five times with PBS. Cells were bathed in new medium and reincubated
at 37°C in 5% CO2. Supernatants were collected 48 and 120 h after infection, and
plaque assays were performed on 293 cells by serial dilution.
E2F4 antibody generation. To generate a polyclonal anti-E2F4 antibody, a
peptide corresponding to the 15 C-terminal residues of human E2F4 (SEGVC
DLFDVPVLNL) was used to immunize rabbits. The antibody was subsequently
affinity purified on a peptide column.

RESULTS
E1A 13S activates E2F genes in a pRb-independent manner.
Previously, it was reported that E1A can interact with E2F6
(21). We were intrigued by this observation and wanted to
determine whether an interaction between E1A and E2Fs had
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a direct effect on E2F-mediated transactivation independently
of E1A binding to pRb. It was necessary to discriminate between E1A’s association with E2Fs and its association with
pRb, because the latter indirectly affects E2F-mediated transcriptional activation. In order to eliminate pRb binding to
E1A, we utilized an E1A deletion mutation (dl1108) that disrupts the highly conserved LxCxE pRb-binding motif. This
mutation largely abrogates E1A binding to pRb (and other
pocket proteins) (14). Intriguingly, we observed that E1A 13S
and E1A 13S dl1108 were both equally efficient in inducing
expression from a transiently transfected E2F-regulated luciferase reporter in asynchronously dividing U2OS cells (Fig.
1A), whereas E1A 12S and E1A 12S dl1108 did not induce
activation of this reporter. A similar result was observed with
the other E2Fs tested (E2F1 to E2F5). In each case, E1A 13S
potently activated expression, whereas E1A 12S moderately
repressed this reporter (data not shown). These results clearly
demonstrate that E1A 13S, but not E1A 12S, can stimulate
E2F-mediated transcriptional activation independently of
binding to the pocket proteins.
In order to determine whether the effect observed with a
plasmid reporter system occurred in a more physiological setting, we engineered a cell line (U2OS-E2F) harboring an integrated pGL-E2F reporter in the cellular chromatin. For
these experiments, a drug-resistant pool was used in order to
minimize the effects of clonal variation. To determine the level
of activation from individual E2Fs, cells were cotransfected
with the indicated E2Fs, DP-1, and the indicated E1A constructs (Fig. 1B). In this context, E1A 13S dl1108, but not E1A
12S dl1108, activated the integrated reporter when an E2F was
present. This suggests that E1A 13S, but not 12S, can activate
E2F-responsive promoters independently of its role in interference with pRb function. Intriguingly, when the two repressive E2Fs (E2F4 and E2F5) were individually cotransfected
with E1A, a “superactivation” was observed that was greater
than double that observed using E2F1, E2F2, or E2F3. This
shows, for the first time, that E1A 13S can directly and specifically influence the expression of genes that are being transcriptionally silenced by repressive E2F4 or E2F5. In effect,

FIG. 1. E1A 13S induces pRb-independent activation of E2F-mediated transcription and binds E2F/DP-1 complexes. (A) U2OS cells
were cotransfected with the reporter plasmid pGL-E2F (having four
synthetic consensus E2F binding sites) together with E2F1 and DP-1
and the indicated E1A constructs or the vector alone. Luciferase assays
were performed 48 h after transfection, and results were normalized to
the protein concentration. Data are plotted as the n-fold increase over
the reporter alone. (B) A U2OS cell line harboring an integrated
(“chromatinized”) pGL-E2F reporter was cotransfected with the indicated E2Fs together with DP-1 and either E1A 12S dl1108 or E1A 13S
dl1108. Luciferase activity was measured 48 h after transfection and is
represented as n-fold activation versus that in cells transfected only
with empty plasmids (vector ⫽ 1). (C) HeLa cells were transfected with
plasmids expressing HA-tagged E2F1 to E2F5, HA-tagged DP-1, and
E1A 13S dl1108 as indicated. Forty-eight hours after transfection, cells
were lysed and immunoprecipitations for E1A were carried out using
M73 anti-E1A monoclonal antibody. Immunoprecipitates were resolved on SDS-PAGE, and associated E2F/DP-1 complexes were detected by Western blotting using anti-HA antibody (3F10). Inputs of
E2Fs, DP-1, and E1A are shown.
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FIG. 2. E1A N terminus binds to DP-1. (A) Schematic representation of E1A-GFP fusion fragments used in the experiment. (B) HeLa
cells were cotransfected with the indicated GFP-E1A fragment fusions
or with E1A 12S or E1A 13S together with HA-tagged DP-1. Either
GFP or E1A (in the cases of E1A 12S and E1A 13S) was immunoprecipitated (IP) from cell lysates and resolved by SDS-PAGE, and
associated DP-1 was detected using anti-HA antibody (3F10). Inputs
of DP-1 and GFP fusion proteins are shown.

E1A 13S appears to be turning a transcriptional repressor into
an activator in this specific context.
Because of the observed differences in the level of transcriptional activation between “activating” E2F1 to E2F3 and “repressive” E2F4 and E2F5, we wanted to determine whether
E1A could bind to the different E2F complexes and whether
the observed differences were due to different affinities for
distinct E2F/DP-1 heterodimers. To test this, we transfected
HeLa cells with E2F1 to E2F5, DP-1, and E1A 13S dl1108 and
carried out coimmunoprecipitations 48 h after transfection
(Fig. 1C). E1A was found to bind to all E2F/DP-1 complexes.
Unexpectedly, binding to E2F4/DP-1 and E2F5/DP-1 was the
weakest and binding to DP-1 was surprisingly strong. In fact,
DP-1 was consistently bound by E1A at an apparent higher
stoichiometry than the corresponding E2F, suggesting that
E1A interacts with DP-1 independently of the E2F subunit.
Together, these results show that E1A 13S, but not E1A 12S,
can activate transcription from E2F-regulated genes in a pRbindependent manner. Furthermore, these results suggest that
E1A binds to DP-1 better than any of the E2Fs.
E1A binds to DP-1 via the N terminus. To identify the area
of E1A required for binding to DP-1, we carried out coimmunoprecipitation experiments with GFP fusions of E1A fragments corresponding to the N terminus (residues 1 to 82), CR2
(residues 93 to 139), CR3 (residues 139 to 204), and the exon
2-encoded region containing CR4 (residues 187 to 289). Only
the N-terminal portion of E1A was capable of interacting with
DP-1 strongly (Fig. 2B). Indeed, DP-1 was readily detected in
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immunoprecipitations despite the relatively low levels of GFP–
E1A-1-82 expression. In addition, a strong association of fulllength E1A 12S and E1A 13S with DP-1 was detected. As
expected, no interaction between GFP alone and DP-1 was
detected (Fig. 2B).
In order to further define the minimal region required for
DP-1 binding, a panel of N-terminal E1A deletion mutant
forms (16) was used in coimmunoprecipitation experiments
(Fig. 3A). Binding to DP-1 was abrogated only when E1A
residues 4 to 25 were deleted (Fig. 3B). All other mutant forms
showed largely normal DP-1 binding (Fig. 3B). As dl1101 deletes a relatively large portion of E1A (residues 4 to 25), we
wanted to further narrow down the binding region. For this
purpose, we constructed a mutant form by removing residues 2
to 11. E1A 12S ⌬2-11 lost all ability to bind to DP-1. Similarly
E1A 13S ⌬2-11 was also largely deficient in binding (Fig. 3C).
Importantly, a double point mutant form of E1A (Y47H and
C124G) that is completely devoid of pRb binding (32) was still
able to efficiently and detectably coimmunoprecipitate DP-1
(Fig. 3C). Deletion of residues 2 to 11 also impacts p300/CBP
binding; therefore, it was necessary to distinguish DP-1 binding
from the p300/CBP interaction. Two point mutant forms of
E1A (R2G and I5A) that no longer bind to p300 in vivo were
still found to detectably interact with DP-1 in the context of the
Y47H and C124G background (Fig. 3D). These results demonstrate that E1A interacts with DP-1 via the N terminus, with
residues 2 to 11 being essential for binding, and further show
that this interaction occurs independently of the ability of E1A
to associate with the pRb family of proteins or p300/CBP.
Residues 1 to 102 of DP-1 are required for binding to E1A.
In order to determine the region of DP-1 bound by E1A, we
used a series of deletion mutant forms of DP-1 (Fig. 4A) (34).
Deletions within the DNA-binding (residues 103 to 126) or
dimerization (residues 232 to 272) domain had no effect on the
interaction between DP-1 and E1A 12S or E1A 13S (Fig. 4B,
left panel). Deletion of the C terminus of DP-1 up to residue
233 did not reduce binding compared to that of full-length
DP-1. Indeed, several deletion mutant forms bound E1A substantially better (Fig. 4B, right panel). However, the deletion of
N-terminal amino acids 1 to 127 completely abolished the
interaction between DP-1 and E1A and any further deletions
from the N terminus also produced a failure to bind. It should
be noted that the nature of the prominent band above the main
DP-1 band in the coimmunoprecipitation between E1A and
DP-1 amino acids 1 to 346 is unknown, but the lack of this band
in any other immunoprecipitation lanes suggests that it is an
artifact of this truncated mutant form of DP-1. Nevertheless,
these results indicate that the N terminus of DP-1, comprising
the first 102 amino acids, is required for binding with E1A.
To determine whether E1A bound to endogenous DP-1
during viral infection, normal human lung fibroblast IMR-90
cells were infected with viruses expressing wild-type E1A 12S,
E1A 12S ⌬2-11 Y47H/C124G, or E1A 13S (Fig. 5A). E1A 12S
was readily able to coprecipitate associated DP-1 (Fig. 5A,
lanes 3 and 4), whereas the triple mutant form E1A 12S ⌬2-11
Y47H/C124G failed to bind to DP-1 (Fig. 5A, lanes 5 and 6).
This result agrees with our earlier observations showing that
the N terminus of E1A was critical for DP-1 binding (Fig. 2 and
3). E1A 13S also coprecipitated DP-1; however, the amount
was less than that obtained with E1A 12S. This was most likely
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due to the lower level of expression of E1A 13S during infection (Fig. 5A, compare E1A input lanes 3 and 4 with lanes 7
and 8). Furthermore, E1A was able to bind to endogenous
E2F4 in the same cells following viral infection (Fig. 5B) but
this binding was completely lost when residues 2 to 11 were
deleted along with mutations in the pRb-binding regions
(Y47H and C124G). To our knowledge, this represents the
first in vivo demonstration that E1A can stably interact with
E2F4 or DP-1.
Together, these results show that E1A bound to the N terminus of DP-1 and this occurred during normal viral infection.
E1A 13S binds directly to the DP-1/E2F1 complex and DP-1
alone. E2F/DP-1 heterodimers are intricately regulated and
form complexes with many other binding partners (11), which
could be mediating the interaction with the N terminus of
E1A. Therefore, it was important to determine whether E1A
directly targets DP-1 and/or the E2F/DP-1 complex. This is
particularly important from the viewpoint of E1A, since the N
terminus of E1A associates with many transcriptional coregulators, some of which also bind to E2F/DP-1 complexes (24).
Our use of the dl1107, dl1108, and Y47H/C124G mutants in
the work presented here allowed us to rule out the pRb family
of proteins (pRb, p107, and p130) as potential mediators of
this interaction. Furthermore, p300 and CBP were ruled out as
potential mediators of the interaction between E1A and DP-1
by the use of R2G and I5A point mutant E1As. To determine
whether E1A directly associates with DP-1, we used a GST
pulldown approach with purified recombinant proteins (Fig.
6). GST, GST–DP-1/E2F1-6⫻His complex, and GST–DP-1
were used to determine whether they could pull down purified
recombinant E1A 13S using glutathione Sepharose beads. As
expected, GST alone was not capable of detectable interaction
with E1A 13S in vitro. However, the recombinant DP-1/E2F1
complex or DP-1 alone detectably pulled down E1A 13S, demonstrating that this interaction is direct. Interestingly, there
was a substantial difference between the level of E1A 13S
pulled down by the DP-1/E2F1 heterodimer and that pulled
down by DP-1 alone. Nevertheless, these results clearly show
that E1A 13S directly interacts with the DP-1/E2F1 complex
and DP-1 alone in vitro.
E1A is recruited to E2F-regulated promoters and selectively
activates gene expression. Our data suggest that E1A 13S, but

FIG. 3. E1A residues 2 to 11 are required for pRb-independent
association with DP-1. (A) Schematic representation of E1A exon 1
showing the mutant forms used in the study. N-Term., N terminus.
(B) HeLa cells were cotransfected with vectors expressing the indicated E1A 12S deletion variants and HA–DP-1. Cells were lysed 48 h
after transfection, and immunoprecipitations (IP) were carried out
using anti-E1A antibody (M73). Associated DP-1 was detected using
anti-HA antibody (3F10). Input levels are indicated. (C) HeLa cells
were cotransfected with vectors expressing the indicated E1A proteins
and HA–DP-1. Cells were lysed 48 h after transfection, and E1A
immunoprecipitations were carried out using anti-E1A antibody
(M73). Associated DP-1 was detected using anti-HA antibody (3F10).
Input levels are indicated. (D) HeLa cells were cotransfected with
vectors expressing the indicated E1A proteins and HA–DP-1. Cells
were lysed 48 h after transfection, and E1A was immunoprecipitated
with anti-E1A antibody (M73). Associated DP-1 was detected using
anti-HA antibody (3F10). Input levels are shown. wt, wild type.
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FIG. 4. DP-1 N terminus is required for association with E1A. (A) Schematic representation of DP-1 and deletion mutant forms used in this
study. (B, left) HeLa cells were cotransfected with either E1A 12S or E1A 13S and the indicated deletion mutant forms of DP-1. Cells were lysed
48 h after transfection, and E1A was immunoprecipitated (IP) using anti-E1A antibody (M73). Associated DP-1 was detected using anti-HA
antibody (3F10). (B, right) HeLa cells were cotransfected with the indicated deletion mutant forms of DP-1 and the Y47H/C124G double mutant
form of E1A 12S that is unable to bind to pRb. Cells were lysed 48 h after transfection, and E1A was immunoprecipitated using anti-E1A antibody
(M73). Associated DP-1 was detected using anti-HA antibody (3F10). Inputs are shown for all immunoprecipitations. wt, wild type.

not E1A 12S, could specifically activate E2F-responsive promoters (Fig. 1A). Interestingly, when the E2F reporter was
integrated into cellular chromatin, E1A 13S led to enhanced
reporter activation with the two repressive E2Fs, E2F4 and
E2F5 (Fig. 1B). This observation suggests that E1A 13S may
specifically enhance expression from E2F-regulated promoters, particularly those that are being repressed by the silencing
E2F complexes. To address this, we performed ChIP, followed
by real-time PCR quantification, in order to determine the
occupancy of E1A and E2F4 on the PCNA and MCM4 pro-

moters during viral infection of arrested IMR-90 cells. The
PCNA and MCM4 promoters were chosen because both are
regulated by E2Fs and it was previously reported that the
PCNA promoter is occupied by repressive E2F4 (7, 9, 27)
whereas MCM4 is not. We infected G0/G1-arrested IMR-90
cells with viruses that expressed no E1A (E1 deleted), E1A 12S
only (dl520), E1A 13S only (pm975), or wild-type genomic E1A
(expresses all isoforms; dl309) and performed ChIPs and reChIPs 24 h after infection (Fig. 7A and B). Both E1A isoforms
were found to occupy the PCNA promoter, with E1A 13S
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FIG. 5. E1A binds endogenous DP-1 during viral infection.
(A) IMR-90 cells were infected with adenoviruses expressing the indicated E1A isoforms (no E1A [Mock], E1A 12S, E1A 12S ⌬2-11
Y47H/C124G, or E1A 13S). Twenty-four hours after infection, cells
were lysed and E1A was immunoprecipitated (IP) using anti-E1A
(M73) antibody. Associated DP-1 was detected using anti-DP-1 antibody (WTH24). Each experiment was done twice from two independent infections. Inputs of DP-1 and E1As are shown. (B) IMR-90 cells
were infected with adenoviruses expressing the indicated E1A isoforms
(no E1A [Mock], wild-type genomic E1A [dl309], wild-type E1A 13S,
or E1A 13S Y47H/C124G ⌬2-11). Twenty-four hours after infection,
the cells were lysed and E1A was immunoprecipitated using anti-E1A
(M73) antibody. Associated endogenous E2F4 was detected using a
C-terminal E2F4 antibody. Inputs of E2F4 and E1A are shown.

having the highest level of occupancy (Fig. 7A, left panel). The
occupancy of E1A at the MCM4 promoter was quite different
from what we observed with the PCNA promoter. Unlike at the
PCNA promoter, E2F4 was not previously reported to be present at the MCM4 promoter (7, 9, 27). During infection with
virus expressing E1A 13S alone (pm975), E1A was present at
the MCM4 promoter at a relatively high level (⬃8% of the
input; Fig. 7B, left panel). During infection with virus expressing E1A 12S alone (dl520), the level of occupancy by E1A was
considerably lower, although it was well above the background
level. Furthermore, there was low overall E1A occupancy at
the MCM4 promoter when E1A 12S and E1A 13S were coexpressed. Our results with E1A occupancy at the PCNA and
MCM4 promoters suggest that E1A 13S is efficiently gaining
access to these promoters perhaps via the repressive E2Fs. To
investigate this possibility, we performed ChIP for E2F4, followed by re-ChIP for E1A (Fig. 7A and B, middle and right
panels). E2F4 was found to occupy both the PCNA and
MCM4 promoters, although occupancy at the PCNA promoter was approximately double that found at the MCM4
promoter. Interestingly, we found that the presence of E1A
13S correlated with enhancement of E2F4 occupancy at these
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FIG. 6. E1A 13S binds directly to DP-1/E2F1 and DP-1 alone. GST
pulldown assays were carried out with the purified DP-1/E2F1 complex
and purified E1A 13S or DP-1 and E1A 13S alone. GST was used as
a negative control. E1A pulled down by DP-1/E2F1 or DP-1 alone was
detected using anti-E1A (M73) antibody. Inputs are shown.

two promoters (Fig. 7A and B, middle panels). Furthermore,
re-ChIP experiments with E1A indicate a preference for E1A
13S to be present along with E2F4 at the PCNA and MCM4
promoters.
The ChIP experiments indicate that the different isoforms of
E1A have different promoter occupancy patterns. However,
these results do not tell us how these genes are transcriptionally regulated. For gene expression analysis, we infected arrested IMR-90 cells with each virus at a different MOI in order
to produce similar levels of E1A expression, which are shown
in Fig. 7C. To determine the transcriptional activity of E2F
target genes, we performed real-time quantitative reverse
transcriptase PCR (qRT-PCR) of PCNA, BLM, and MCM4
transcripts following viral infection of arrested IMR-90 cells
36 h after infection with viruses that expressed no E1A (E1
deleted), E1A 12S only (dl520), E1A 13S only (pm975), E1A
13S ⌬2-11, or wild-type genomic E1A (expresses all isoforms;
dl309) (Fig. 7D). Results are expressed as the relative n-fold
change in the expression level over that in the virus with E1
deleted. Transcriptional activation of these E2F-responsive
genes was found to be the highest with the E1A 13S-only virus,
while the E1A 12S and genomic viruses induced considerably
lower expression levels, with the exception of PCNA (Fig. 7D).
Importantly, deletion of the N-terminal DP-1-binding domain
in the E1A 13S-only virus caused a severe reduction of gene
activation with respect to pm975. Indeed, activation was below
the levels seen with the E1A 12S virus and largely equivalent to
those obtained with the virus with E1 deleted.
These results demonstrate that E2F4 is recruited to both the
PCNA and MCM4 promoters. Significantly, E1A 13S, but not
E1A 12S, induced enhanced E2F4 promoter occupancy and
largely only E1A 13S was found to co-occupy the PCNA and
MCM4 promoters together with E2F4 and presumably DP-1.
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FIG. 7. E1A is recruited to E2F-regulated promoters, altering E2F4 occupancy and E2F target gene expression. (A) ChIPs and re-ChIPs were
carried out for E1A (using M73 antibody), E2F4 C-terminal antibody, or IgG control antibody (mouse anti-rabbit) in arrested IMR-90 cells
infected with adenovirus with E1 deleted, virus expressing only E1A 12S (dl520), virus expressing only E1A 13S (pm975), or virus expressing
genomic E1A (both E1A 12S and 13S; dl309). Immunoprecipitations were carried out 24 h after infection. Occupancy of E1A and E2F4 was
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Furthermore, these results show that there are differences in
how E1A 12S and E1A 13S influence gene expression, which
differ from how wild-type genomic E1A alters the cellular
transcriptional program.
E1A residues 2 to 11 and CR3 are required for efficient
S-phase induction and viral replication. We have observed
that E1A 13S is preferentially targeted to E2F-regulated promoters, and this leads to induction of E2F target gene expression (Fig. 7). The activation of E2F-responsive genes was also
dependent on the N terminus of E1A, which binds to DP-1. To
test whether this had an impact on the induction of S phase and
viral replication, we undertook a series of BrdU incorporation
assays with arrested IMR-90 cells and a virus growth assay
(Fig. 8). E1A 13S-expressing virus was found to be better at
inducing S phase than E1A 12S-only-expressing virus. In fact,
E1A 13S was almost equivalent to the wild-type genomic E1A
virus at inducing cellular DNA replication (Fig. 8A). The ability of E1A 13S to induce S phase was diminished significantly
when residues 2 to 11 were deleted; these amino acids are
required for efficient binding of DP-1 to E1A. Finally, we have
also observed that the E1A 13S-expressing virus grew an average of 100 times better than the E1A 12S-only-expressing
virus (Fig. 8B). Together, these results demonstrate the importance of the N terminus targeting of DP-1 and a role for CR3
of E1A in inducing S phase and leading to efficient viral replication and growth.
DISCUSSION
To date, the study of how E1A deregulates the E2F family of
transcription factors has been focused largely on the smaller
isoform of E1A encoded by the 12S splice variant of human
adenovirus 5 (3). This is paradoxical in a sense because E1A
12S is largely thought to be a transcriptional repressor (2, 16,
18), despite its ability to activate E2F target genes indirectly by
interfering with pocket protein function. The recent observation that E1A, and the functionally equivalent HPV E7 protein, can bind to E2F6 (21) suggests that E1A could directly
affect E2F-regulated transcription. Our previous work has
shown that the larger E1A 13S isoform encoded by adenovirus
5 can utilize cellular factors for tethering directly to promoters
in order to activate the transcription of viral (25) and cellular
(24) genes, while others have shown that E1A 12S can be
recruited to a large array of cellular promoters and alter their
activity (12). Based on these observations, we have reevaluated
the role that each major isoform of E1A has in altering E2F
transcription factor function.
We report here a direct and hitherto unsuspected interaction between E1A and DP-1. Indeed, E1A may be universally

FIG. 8. CR3 and the N-terminal DP-1-binding domain are required
for efficient induction of S phase and virus growth. (A) Arrested IMR-90
cells were infected with the indicated adenoviruses, pulsed with BrdU for
1 h at the indicated time points, fixed, and stained with anti-BrdU antibody. Results are expressed as a percentage of BrdU-positive nuclei and
constitute a mean of three random fields of view at a low magnification.
(B) Arrested IMR-90 cells were infected with pm975 or dl520 virus at an
MOI of 5, and medium was assayed for cell-free virus 48 and 120 h after
infection by a plaque assay on 293 cells.

assessed for the PCNA promoter around E2F sites by qRT-PCR and is expressed as a percentage of the input. (B) ChIPs and re-ChIPs were carried
out for E1A (using M58 and M73 antibodies), E2F4 (using a custom rabbit E2F4 antibody), or IgG control antibody (mouse anti-rabbit) in arrested
IMR-90 cells infected with either adenovirus with E1 deleted, virus expressing only E1A 12S (dl520), virus expressing only E1A 13S (pm975), or
virus expressing genomic E1A (both E1A 12S and 13S; dl309). Immunoprecipitations were carried out 24 h after infection. Occupancy of E1A and
E2F4 was assessed for the MCM4 promoter around E2F sites using qRT-PCR and is expressed as a percentage of the input. (C) Expression levels
of various E1A mutant adenoviruses in infected IMR-90 cells 24 h after infection. Arrested IMR-90 cells were infected with the indicated viruses
and lysed, and E1A levels were detected using anti-E1A (M73) antibody. Actin was used as a loading control. (D) Real-time PCR quantification
of expression levels of the PCNA, MCM4, and BLM gene products at 36 h after infection of arrested IMR-90 cells. The results are expressed as
n-fold changes versus cells infected with adenovirus with E1 deleted.
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targeting DP-1 in order to gain efficient access to all E2Fregulated promoters without having to individually target the
different E2Fs themselves. In vitro binding experiments show
that the interaction of E1A with DP-1 is direct (Fig. 6). However, there was an observable difference in the affinities of E1A
for DP-1 alone and DP-1 in complex with E2F1. This suggests
that E1A may preferentially target the DP-1 heterodimer,
rather than the monomer, which usually is not found in vivo.
Alternatively, DP-1 alone simply may not fold properly when it
is not in a complex with an E2F and therefore lacks the optimal
E1A-binding surface. Binding of E1A to DP-1 was found to
occur via the N terminus of E1A targeting the N terminus of
DP-1 (Fig. 2, 3, and 4). This region of E1A is present in both
E1A 12S and 13S. It is not highly conserved between the E1A
proteins of various human and simian adenoviruses but binds
a large number of cellular proteins (24). The region of DP-1
bound by E1A encompasses neither the DNA-binding nor the
dimerization domain, suggesting that these functions of DP-1
must remain intact while in complex with E1A. This agrees
with our observations indicating that E1A can use E2F/DP-1
complexes to target itself to promoters, which would not occur
if E1A interfered with either the DNA-binding or the
dimerization function of DP-1.
Consistent with our identification of a direct interaction
between E1A and DP-1, we determined that E1A 13S can
activate expression from E2F-regulated promoters in a fashion
that does not rely on E1A binding to pRb or other pocket
proteins in asynchronously dividing cells (Fig. 1A and B). This
occurred with all of the E2Fs tested (Fig. 1B), which is consistent with E1A targeting DP-1 directly and using it to localize
E1A 13S at the promoter. The presence of the strong transactivation domain (CR3) in E1A was required for activation of
the E2F reporter in this context, since E1A 12S was unable to
induce transcription. This was somewhat unanticipated, as we
would expect some degree of activation due to relief of pRbmediated repression. It is likely that E1A 12S is unable to
activate E2F-dependent transcription in asynchronously dividing cells because relief of pRb-mediated repression in the
absence of CR3-dependent activation is not sufficient to efficiently drive expression above the basal activity of the reporter
in these cells, where pRb function may be partially compromised. Conceivably, as both E1A 13S and 12S can bind DP-1
(Fig. 2B), either E1A protein could be recruited to E2F-responsive promoters. This could potentially establish a competition for occupancy that may serve as a means of fine-tuning
transcriptional activation. Indeed, a previous study (12)
showed that E1A 12S is still recruited to E2F-regulated promoters in the absence of pRb binding.
Activation of transcription by E1A 13S was significantly
greater with E2F4 and E2F5 than with E2F1 to E2F3 (Fig. 1B).
E2F4 and E2F5 are considered repressive members of the E2F
family, whereas E2F1 to E2F3 are considered activators. This
raises the intriguing possibility that E1A can preferentially
target genes repressed by E2F for activation, rather than those
already efficiently transcribed. This economy of action is reminiscent of the ability of E1A to bind hypophosphorylated
active pRb but not hyperphosphorylated inactive pRb (22).
Furthermore, some of the activating E2Fs (in particular, E2F1)
can be strongly proapoptotic (30, 35). Presumably, such E2Fs
are not superactivated by E1A, as this could lead to premature
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cell death and an abortive infection. It is still unclear how E1A
achieves high activation levels through E2F4 and E2F5, but it
is not simply due to higher affinity, as we observed a relatively
weak association between E1A 13S and DP-1/E2F4 or DP-1/
E2F5 (Fig. 1C). This ability of E1A 13S to transform a transcriptional repressor into an activator closely parallels what we
have previously observed with CtBP and ZNF217 (5).
qRT-PCR and ChIP results shed an interesting light on how
E1A deregulates transcription from E2F-responsive genes. Although previous reports (12, 29) showed that E1A 12S is recruited to E2F-regulated promoters and alters the composition
of factors at these promoters, the role of E1A 13S in altering
gene expression patterns has never been examined in detail.
Here we report clear differences in the ways in which the
different E1A isoforms regulate gene expression from E2Fresponsive promoters. Our results indicate that E1A 13S is
preferentially co-occupying PCNA and MCM4 promoters together with E2F4/DP-1, whereas there is little E1A 12S present. Interestingly when both E1A 12S and E1A 13S are coexpressed, as is the case with the dl309 virus, we see a reduction
of overall E1A occupancy and co-occupancy on these two
promoters. This suggests that E1A 12S can somehow prevent
E1A 13S from gaining full access to the promoter. The differences observed between E1A ChIP and re-ChIP following
E2F4 ChIP suggest that there is more than one way in which
E1A can access these promoters. This is not surprising, as
many factors contribute to transcriptional activation and E1A
itself binds a wide array of transcriptional coactivators (24).
Intriguingly, we observed a considerable enhancement of E2F4
occupancy at the PCNA and MCM4 promoters following infection where E1A 13S was present. A previous study showed
that adenovirus E4 orf6/7 protein could induce nuclear translocation of E2F4 and enhanced promoter occupancy (28). This
presents an intriguing axis of viral protein cooperation where
E1A 13S induces expression of the E4 region, including E4
orf6/7, which then leads to enhanced occupancy by E2F4/DP-1
at target promoters that is subsequently utilized by E1A 13S to
drive gene expression from otherwise repressed genes. Indeed,
another E4 protein, E4 orf4, appears to play a role in regulating expression from E2F-responsive genes, highlighting the
importance of activation of the E4 region by E1A 13S (19, 23,
26, 28). A recent study also demonstrated that a large proportion of the genes turned on in quiescent mouse 3T3 fibroblasts
by E1A 12S were E2F4 targets (10), suggesting that this may be
an important mechanism driving E2F target gene expression.
In the present study, induction of cellular E2F target genes was
also found to be the highest for those viruses that expressed
E1A 13S. Importantly, we observed an almost total ablation of
E2F gene activation when cells were infected with a deletion
mutant form of E1A 13S that lacks the N-terminal DP-1binding domain, signifying the importance of this region in
driving E2F-responsive genes. Furthermore, while E1A 13S
⌬2-11 was also impaired for induction of S phase, it was similar
to E1A 12S. This may result from the ability of this mutant
form to still bind to pRb and relieve E2F repression by displacing pRb or other pocket proteins. Interestingly, we observed large differences in the ways in which the different E1As
were able to activate cellular gene expression. Unexpectedly,
the wild-type E1A virus (dl309) was only slightly better than
the E1A 12S virus at driving E2F-responsive genes, but it was
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considerably better at inducing S phase. A fine control of the
transcriptional program enabled by multiple variants (such as
the different isoforms of E1A) may allow for optimal gene
expression most suitable for virus growth. This hypothesis is
further supported by transcriptional activation of E2F-regulated genes by the genomic E1A virus. The wild-type genomic
virus showed only a moderately higher level of transcriptional
activation than the E1A 12S-only virus, despite lower levels of
promoter occupancy by E1A-expressing virus than by E1A
13S-expressing virus. However, it was still as efficient as E1A
13S in driving quiescent cells into S phase. This highlights the
importance of having all E1A isoforms present and suggests
that the wild-type virus has evolved complex mechanisms for
optimally modulating gene expression.
In conclusion, we show for the first time that E1A directly
associates with E2F/DP-1 complexes, likely through binding to
DP-1. This potentially endows E1A with the ability to directly
influence E2F-responsive genes without relying only on the
deregulation of the pRb family of proteins. Interestingly, this
activation of transcription may be restricted largely to E2Frepressed genes by E1A 13S and appears to be modulated in a
competitive fashion by E1A 12S. The hitherto unappreciated
tripartite complexity of functional interactions between pRb
family of proteins, E2Fs, and various isoforms of E1A described here illustrates the extremely tight relationship between the infecting adenovirus and the host cell. Finally, our
work suggests a novel functional cooperation axis whereby one
viral gene (that for E1A 13S) induces the expression of another
(that for E4 orf6/7), which then assists the first in carrying out
its function, highlighting the tight relationships between all
viral genes and the overriding importance of driving the infected cell into S phase.
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